NSB 12.8% 3.4¢ neuroscientific biopharmaceuticals ltd

NSB

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,355 Posts.
    lightbulb Created with Sketch. 816
    @MSIMaker Thought you might be interested...

    https://unauthorised investment advice/health/gold-coast-investment-showcase-wrap-day-2/amp/

    Neuroscientific
    Biopharma non-executive chairman Brian Leedman championed the Alzheimer’s-fighting drug the company is getting set to trial could be “the greatest drug of all time”.

    “There can’t be a bigger prize than finding a treatment for dementia.”

    The Perth business (ASX:NSB) has raised $6m in an oversubscribed initial public offer and plans to list on the ASX in the middle of next month. Leedman said the business was optimistic its drug, which has so far only be tested in rats, that it can regenerate neurons and then capture the attention of buyers.

    “As we go through the clinical trial program, we will get the attention of big pharma, and they will buy us,” Mr Leedman said.

    Cheers

    Red bar
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
-0.005(12.8%)
Mkt cap ! $5.639M
Open High Low Value Volume
3.7¢ 3.7¢ 3.4¢ $21.49K 608.0K

Buyers (Bids)

No. Vol. Price($)
3 7060 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 12035 2
View Market Depth
Last trade - 15.58pm 27/09/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.